About Karbinal ER
Karbinal ER is a Healthcare company based in Chesterfield (United States) founded in 2011, and was acquired by Cerecor in February 2018. Information on allergy drugs is provided through an online platform. Its focus areas include Pharmaceutical Product Websites.
Company details
Karbinal ER was established in 2011 in Chesterfield, United States. Operations are centered on a website that delivers detailed information about allergy medications. The platform serves the healthcare information sector by offering resources on drug usage, side effects, and related treatments. Content is tailored for users seeking reliable data on allergy management. No physical products are distributed; focus remains on digital accessibility for educational purposes.
- Headquarters Chesterfield, United States
- Stage Acquired
- SectorsHealthcare
- Website karbinaler.com
- Acquired by Cerecor (Feb 2018)
Investors in Karbinal ER
Karbinal ER has secured backing from 1 investor. Prominent investors backing the company include Cerecor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutics for immunological and neurological disorders are developed. | 2011 | cerecor.com | Baltimore, United States |
Investor details for Karbinal ER
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Karbinal ER
2 dated milestones of Karbinal ER across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Karbinal ER is founded.
- Exit Acquired by Cerecor.
Web traffic of Karbinal ER
The website of Karbinal ER (karbinaler.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 150.1% vs previous month
Top companies in Pharmacy & Healthcare Retail Systems
3 companies that operate in the same segment as Karbinal ER (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 | ||
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Karbinal ER
Karbinal ER was founded in 2011.
Karbinal ER is headquartered in Chesterfield, United States. It is registered at Chesterfield, Missouri, United States.
Karbinal ER was established in 2011 in Chesterfield, United States. Operations are centered on a website that delivers detailed information about allergy medications. The platform serves the healthcare information sector by offering resources on drug usage, side effects, and related treatments. Content is tailored for users seeking reliable data on allergy management. No physical products are distributed; focus remains on digital accessibility for educational purposes.
Karbinal ER has 1 investor. Key investors include Cerecor.
Yes. Karbinal ER was acquired by Cerecor in February 2018.